CompletedNANCT07105137

Artificial Intelligence-Assisted Expressive Writing Intervention to Improve Adolescent Emotional Distress: A Cluster Randomized Controlled Trial

Sponsor: Peking University

Trial Details

ConditionEmotional Disturbance, Emotional Regulation, Insomnia
InterventionAI-GNW; NF-GNW; NWG
PhaseNA
StatusCompleted
Participants486
Est. Completion25 Oct 2025
Last Updated10 June 2026

Primary Outcome

Revised Child Anxiety and Depression Scale (RCADS)

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * Native speakers of Chinese who are proficient in reading and writing Chinese. * Signed a informed consent form and voluntarily agreed to participate. * Owns a smartphone, tablet, or similar electronic device and is able to complete the required questionnaires and writing tasks. Exclusion Criteria: * Prior clinical diagnosis of schizophrenia or any other major psychiatric disorder. * Presence of severe cognitive impairment, language-expression difficulties, or any other condition that would impede writing ability. * Participation in another similar psychological intervention or psychotherapy within the past three months. * Inability to tolerate a group-based intervention setting due to personal health conditions (e.g., serious illness). * Unwillingness or inability to provide necessary cooperation or to sign the informed consent form.

Trial Sites

Countries

China
View Registry Entry

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service